An Expert’s Experience in Prescribing Tebentafusp and Other Therapies for mUM and a Commentary on Patient Education and Resources
Dr Sunandana Chandra highlights her personal experience in prescribing tebentafusp and other therapies for mUM, and discusses the educational resources and advocacy organizations that she encourages patients to look into to help make an informed decision about their treatment regimens.
EP: 1.How Uveal Melanoma Differs from Cutaneous Melanoma
EP: 2.Common Symptoms of Uveal Melanoma and the Typical Diagnostic Journey of the Patient
EP: 3.Historic and Current Treatment Options for mUM
EP: 4.Implications of Clinical Trial Data on Bispecific T-Cell Receptor Immunotherapy for mUM
EP: 5.Patient Eligibility and Logistical and Safety Considerations for Tebentafusp Treatment in mUM
Now Viewing
EP: 6.An Expert’s Experience in Prescribing Tebentafusp and Other Therapies for mUM and a Commentary on Patient Education and Resources
EP: 7.Treatment Options for Patients with mUM Who Are Ineligible for Bispecific T-Cell Receptor Immunotherapy
EP: 8.Advice for Patients Living with Metastatic Uveal Melanoma
Related Videos
Related Content
